Development and Validation of an ADL-score Based on FIM and EBI
NCT ID: NCT03233789
Last Updated: 2019-01-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
265 participants
OBSERVATIONAL
2015-11-01
2017-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The following steps are performed:
1. Development of an ADL-algorithms by experts
2. Validation of the ADL-algorithms in a quantitative approach
3. Finalization of the ADL-algorithms by experts based on study results
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Day Time Activity Level in Inpatient Neurological Rehabilitation as Related to Functional Outcomes at Discharge, Length of Stay, Discharge Location, and Quality of Life: a Preliminary Study
NCT04065178
Participative Rehabilitation in Stroke Patients
NCT00687869
Reaching Clinical Recommendations for Intensity of Post-stroke Rehabilitation
NCT04787315
Predictive Indices of Independent Activity of Daily-living in Neurorehabilitation
NCT04691102
Biomarkers to Predict Gain From Therapy in Motor Stroke
NCT03739892
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
neurologic rehabilitation
in-patient rehabilitation of neurologic disorders
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Association nationale pour le développement de la qualité dans les hôpitaux et les cliniques (ANQ), Bern, Switzerland
UNKNOWN
Martin Brünger
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Martin Brünger
Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Karla Spyra, Prof. Dr.
Role: STUDY_DIRECTOR
Charite University, Berlin, Germany
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
U1111-1223-6650
Identifier Type: OTHER
Identifier Source: secondary_id
ANQ-FIM-EBI
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.